Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Twist Bioscience Corporation logo

Twist Bioscience Corporation (TWST) Stock Ticker

NASDAQ: TWST · Healthcare · Biotechnology
$179.88-0.65%
USD · as of 2026-09-28 · market cap $11.4B
Open TWST in TickrRead the TWST AI analysisDownload for iPhone

TWST right now

Up 27% in a month — 28 points ahead of its industry.
bullishBreaking out: New 52-week high with a golden cross
Tickr signals on TWST
Breaking outNew 52-week high with a golden cross
Options expect by Oct 6±14.0%
Options expect by Oct 29±29.0%
Priced in for Nov 13 earnings±35.5%
IV rank (30-day)97% · rich
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full TWST picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on TWST
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Twist Bioscience Corporation

Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.

TWST stock facts

Ticker symbolTWST
ExchangeNASDAQ Global Select
SectorHealthcare
IndustryBiotechnology
Market cap$11.4B
CEOEmily Marine Leproust
Employees979
HeadquartersSouth San Francisco, CA, US
IPO date2018-10-31
Websitewww.twistbioscience.com

What you can see for TWST on Tickr

Live TWST price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the TWST report.

Rankings

Largest Healthcare companiesLargest companies by market cap

TWST peers

BGMCLOVEWTXGPCRGRDNMESOPRCTQDEL

FAQ

What is the ticker symbol for Twist Bioscience Corporation?

The ticker symbol for Twist Bioscience Corporation is TWST, listed on the NASDAQ Global Select.

What is TWST?

Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed…

HomeExploreMarketLists
All pages